Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Biological
  • Participants: 25
  • Start Date: June 23, 2021
Viral Specific T-Lymphocytes by Cytokine Capture System (CCS) to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus After Hematopoietic Cell Transplantation or Solid Organ Transplantation and in Patients With Compromised Immunity
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 5000
  • Start Date: May 1, 2021
Congenital Cytomegalovirus Infection in Vietnam: Prevalence, Morbidity and Risk Factors
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: April 2021
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - STEP 1
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 800
  • Start Date: April 1, 2021
Deep Learning-based System for Detection of AIDS-related Cytomegalovirus Retinitis in Ultra-Widefield Fundus Images
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 840
  • Start Date: January 11, 2021
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 135
  • Start Date: January 1, 2021
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, Without Ultrasound Signs or With Non-serious Ultrasound Signs of Maternal-fetal CMV Infection.
Clinical Trial
  • Status: Recruiting
  • Participants: 40
  • Start Date: November 2020
Breakthrough CMV DNAemia in CMV Seronegative Recipients of CMV Seropositive Lung Transplantation During Antiviral Prophylaxis With Valganciclovir. A Pilot Study.
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 400
  • Start Date: September 24, 2020
Real-life Observatory of Efficacy and Resistance to Anti CMV Molecules in Stem Cell Recipients
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: September 15, 2020
Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients Following Ganciclovir Prophylaxis Until Day +100
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Diagnostic Test
  • Participants: 188
  • Start Date: June 12, 2020
Phase IV Clinical Trial, Open, Randomized, Controlled and Multicentric, With Two Parallel Groups, to Assess the Efficacy of a Preventive Strategy Against Cytomegalovirus Infection in Heart Transplant Patients, Based on the Specific Basal T Cell Response Against Cytomegalovirus: ELISPOT-TC
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 108
  • Start Date: June 1, 2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 400
  • Start Date: March 1, 2020
Incidence, Natural History and Outcome of Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
Showing 1-12 of 50